FDA NDC Directory · JSON-LD · Markdown

Olanzapine and Fluoxetine

NDC 42291-652 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerAvKARE
Marketing categoryAbbreviated NDA (generic) · App ANDA202074
Dosage form / routeCAPSULE · ORAL
Active ingredientsFLUOXETINE HYDROCHLORIDE (25 mg/1)
OLANZAPINE (3 mg/1)
Marketing started20140121
Package count1

External sources

Source: openFDA. Public-domain (CC0).